Novartis’ Entresto team has earned the ire of the PMCPA. For the third time in 12 months, the U.K. drug promotion watchdog ...

Sam Slutsky, an analyst from LifeSci Capital, maintained the Buy rating on Olema Pharmaceuticals (OLMA – Research Report). The associated ...

Novartis agreed to buy US biotech Mariana Oncology Inc. to strengthen its pipeline of drugs that can specifically target ...

Pharmaceutical giant Novartis AG on Thursday said it will pay up to $1.75 billion for a U.S. biotech focused on cancer.

Novartis is firming its role as the top player in the radiopharmaceutical space with the acquisition of Mariana Oncology for ...

Novartis agreed to acquire U.S. radiopharmaceutical company Mariana Oncology for $1 billion upfront, boosting its portfolio ...

Novartis is shelling out $1 billion upfront to buy a Watertown startup that's working to make radiation treatment more ...

With much still to discover in the massive world of radiopharmaceuticals, Novartis will take a deep dive into the unknown ...

Novartis will acquire Mariana Oncology, a Watertown, Massachusetts-based biotech company dealing in radioligand therapies (RLTs) to treat cancer.

Also on this week’s episode, we discuss Novartis’ effort to acquire MorphoSys, and the latest news on Eli Lilly and Novo ...

Novartis has agreed to acquire Mariana Oncology for up to $1.75 billion, the companies said today, in a deal that would ...

Novartis is pumping another $180 million into its radioligand plan, handing the cash to serial dealmaker PeptiDream to expand ...